pembrolizumab
amgen,merck
['melanoma']
 data from our cutaneous oncology team and dr depalo publication on tvec after failure of io for metastatic melanoma being highlighted in the poster discussion session on melanoma #asco2022. 
Chief Academic Officer, Melanoma Surgeon, Surgical Oncologist, Educator, Husband, Father, @moffittnews